Quarterly report pursuant to Section 13 or 15(d)

Segment Reporting (Details)

v3.5.0.2
Segment Reporting (Details) - USD ($)
$ in Thousands
 3 Months Ended
Sep. 30, 2016
Sep. 30, 2015
Jun. 30, 2016
Segment Reporting Information [Line Items]      
Revenues - external customers $ 135 $ 160  
Revenues - intersegment 0 0  
Research and development 820 551  
General and administrative 2,469 1,422  
Operating loss (3,154) (1,813)  
Interest expense (483) 0  
Interest and other income 25 8  
Consolidated net loss (3,612) (1,805)  
Total assets 48,091 11,374 $ 51,600
Fixed assets, net 25,580 10 25,574
Intangible assets, net 2,023 2,284 $ 2,092
Depreciation expense 324 1  
Amortization of intangible assets 88 91  
Operating Segments [Member]      
Segment Reporting Information [Line Items]      
Revenues - external customers 49    
Revenues - intersegment 182    
Research and development 321    
General and administrative 1,271    
Operating loss (1,361)    
Interest expense (483)    
Interest and other income 7    
Consolidated net loss (1,837)    
Total assets 36,330    
Fixed assets, net 25,572    
Intangible assets, net 0    
Depreciation expense 323    
Amortization of intangible assets 0    
Intersegment Eliminations [Member]      
Segment Reporting Information [Line Items]      
Revenues - external customers 0 0  
Revenues - intersegment (334) 0  
Research and development (185) 0  
General and administrative (149) 0  
Operating loss 0 0  
Interest expense 0 0  
Interest and other income 0 0  
Consolidated net loss 0 0  
Total assets (49) 0  
Fixed assets, net 0 0  
Intangible assets, net 0 0  
Depreciation expense 0 0  
Amortization of intangible assets 0 0  
iBio, Inc. [Member] | Operating Segments [Member]      
Segment Reporting Information [Line Items]      
Revenues - external customers 86 160  
Revenues - intersegment 152 0  
Research and development 684 551  
General and administrative 1,347 1,422  
Operating loss (1,793) (1,813)  
Interest expense 0 0  
Interest and other income 18 8  
Consolidated net loss (1,775) (1,805)  
Total assets 11,810 11,374  
Fixed assets, net 8 10  
Intangible assets, net 2,023 2,284  
Depreciation expense 1 1  
Amortization of intangible assets $ 88 91  
iBio CMO [Member] | Operating Segments [Member]      
Segment Reporting Information [Line Items]      
Revenues - external customers [1]   0  
Revenues - intersegment [1]   0  
Research and development [1]   0  
General and administrative [1]   0  
Operating loss [1]   0  
Interest expense [1]   0  
Interest and other income [1]   0  
Consolidated net loss [1]   0  
Total assets [1]   0  
Fixed assets, net [1]   0  
Intangible assets, net [1]   0  
Depreciation expense [1]   0  
Amortization of intangible assets [1]   $ 0  
[1] iBio CMO commenced operations in December 2015.